Freddie vs MISTR vs Q Care Plus: The Honest Comparison

If you have private insurance and your plan is ACA-compliant, all three platforms can get you to $0 for the visit, labs, medication, and shipping. The Affordable Care Act requires most private insurance plans, Medicaid, and Medicare to cover PrEP medications and ancillary services with no cost-sharing as preventive care. MISTR and Freddie both bill insurance directly and absorb any leftover cost through manufacturer copay assistance programs (Gilead's covers up to $7,200/year for Descovy and Yeztugo). Q Care Plus does the same and notes that 99% of insured patients pay $0 out of pocket.

One important wrinkle: MISTR does not accept Kaiser insurance. If you're on a Kaiser plan, your only options here are Freddie or Q Care Plus — both of which work with most insurers including Kaiser.

This is where the platforms separate slightly. The list price of PrEP without any assistance can run $1,500-$2,000+ per month for brand-name medications. None of these three platforms expects you to pay that.

• MISTR markets aggressively to the uninsured: $0 medication, $0 labs, $0 visits, $0 shipping. The platform enrolls uninsured patients in patient assistance programs (primarily Gilead's Advancing Access for Truvada and Descovy) to cover medication. MISTR doesn't bill the patient directly at all.
• Freddie reports that over 90% of all patients pay $0, including the uninsured. The financial assistance team handles enrollment in patient assistance programs.
• Q Care Plus covers visits and labs through community-based organization partners in eligible states, and coordinates copay assistance for medications. The platform notes it's "required to use insurance for the medication if you have an active plan that covers PrEP" — meaning they'll always bill insurance first if you have it.

For someone genuinely without any insurance who wants the most frictionless path, MISTR's positioning is the most explicitly built around your situation. Practical outcome for all three: you pay $0.

This one is binary — either the platform serves your state or it doesn't.

• MISTR: All 50 states, D.C., and Puerto Rico.
• Freddie: All 50 states and D.C. (achieved in November 2025 through ASHA partnership).
• Q Care Plus: 38 states plus D.C. for PrEP. Not available in: Alaska, Hawaii, Maine, Nebraska, New Jersey, New Mexico, North Dakota, Rhode Island, South Dakota, Vermont, West Virginia, or Wyoming.

If you live in one of those 12 states or territories where Q Care Plus doesn't operate, this comparison narrows immediately to MISTR or Freddie. Both have nationwide coverage; the difference is Puerto Rico (MISTR only).

All three platforms prescribe oral PrEP — generic Truvada (emtricitabine/tenofovir disoproxil fumarate) and Descovy (emtricitabine/tenofovir alafenamide). The interesting differences are with injectable PrEP.

• MISTR — Yeztugo (lenacapavir): The first telehealth platform to enroll patients for the twice-yearly subcutaneous shot, FDA-approved June 2025. MISTR administers Yeztugo through seven physical storefronts in major LGBTQ+ neighborhoods, with expanded community-partner access rolling out as state regulations and insurance approvals catch up. If Yeztugo is your priority, MISTR is the only one of the three offering it today.
• Freddie — Apretude (cabotegravir): Freddie has an active Apretude program — the every-2-month intramuscular injection that's been FDA-approved since 2021. The platform handles insurance verification, lab coordination, and logistics. Freddie is preparing to add Yeztugo as insurance coverage expands; the company expects broader rollout in early-to-mid 2026.
• Q Care Plus — Oral only: Q Care Plus explicitly states it currently offers oral PrEP only. No Apretude, no Yeztugo. If you want injectable PrEP, Q Care Plus isn't the option for you right now.

For most people on oral PrEP today, all three are equivalent on this dimension. For anyone considering injectables — and especially the new twice-yearly Yeztugo — MISTR has a structural lead, with Freddie a close second on Apretude.

Every PrEP platform requires baseline labs (HIV, hepatitis B, kidney function) before your first prescription, plus follow-up labs every three months while you're on PrEP. All three offer at-home test kits — but Q Care Plus is the only one that explicitly offers a choice between the at-home kit and an in-person blood draw at a local lab. MISTR and Freddie default to at-home kits, which work for most people but not everyone.

Freddie offers free pickup of completed lab kits or free shipping back; MISTR ships kits but doesn't appear to offer pickup. All three include syphilis testing in their STI panel — important, since some platforms cut corners on syphilis specifically.

MISTR's structural advantage is the asynchronous model. You fill out a 5-10 minute health questionnaire — no scheduled appointment, no waiting room, no time zone juggling. Once your at-home labs are completed and reviewed, your first bottle ships within one business day, and most people receive medication 1-2 days after that. Realistic end-to-end timeline: 7-10 days from sign-up to first pill.

Freddie uses live appointments (call or secure message) but reports next-day appointment availability. The full timeline including labs and shipping is comparable to MISTR — roughly 10-14 days. Q Care Plus uses scheduled video appointments seven days a week including evenings; one user testimonial cited a 2-week turnaround from appointment to medication delivery.

If "today" matters more than "this is the right doctor for me long-term," MISTR's async flow gets you started fastest.

This dimension reverses the speed verdict. The same asynchronous model that makes MISTR fastest also means you may not have a real conversation with a clinician. MISTR's medical team includes MDs, NPs, PAs, and RNs licensed in your state, but you're assigned a provider rather than picking one, and most communication is through the platform.

Freddie uses live appointments — you can choose to meet by phone call or secure message. The provider team is heavily focused on LGBTQ2S+ care.

Q Care Plus is the standout here: you choose your appointment time and your provider during scheduling, and you can stay with that same clinician across visits. Patient reviews repeatedly mention specific providers by name — Anthony, Daniel, Sharee — which is a strong signal that the platform actually delivers continuity. After your initial appointment you can also reach your provider via email, online chat, phone, or video chat through the secure portal.

All three platforms operate on a quarterly cycle: lab work every three months, then a check-in/refill. All three send proactive reminders when it's time to renew. MISTR and Q Care Plus auto-ship medication; Freddie offers a choice between mail delivery and pickup at a local pharmacy — which is a small but real advantage if you want to consolidate prescriptions or prefer same-day pickup. Practically, the refill experience is roughly equivalent across all three.

All three platforms ship medication in unbranded, discreet packaging. None of the three put PrEP-related branding on the outside of the box. If you're on a parent's or partner's insurance plan, be aware that Explanation of Benefits (EOB) statements may still go to the policyholder and could disclose the medication name — that's a function of how insurance works, not anything any platform can control. MISTR explicitly notes this in its FAQ. If absolute privacy from a policyholder matters to you, the safest path is to skip insurance entirely and use the patient assistance program route — which any of the three can help you navigate.

All three platforms position themselves as LGBTQ+ affirming, sex-positive, and stigma-free, and all three appear to deliver on that in practice — based on patient reviews and the explicit framing across each company's site. The differences here are in identity and community focus.

• MISTR is gay-owned and operated; founder Tristan Schukraft built MISTR specifically as an LGBTQ+ sexual health platform, and the company runs the companion platform SISTR for cis and trans women. MISTR also organized the first National PrEP Day in October 2025.
• Freddie uses LGBTQ2S+ language explicitly throughout the site and has a clinical team with deep backgrounds in LGBTQ+ health, HIV prevention, and gender-affirming care.
• Q Care Plus describes its providers as "open-minded, sex-positive, gender-affirming" and operates within Avita Care Solutions, which has a longstanding focus on vulnerable communities.

If having an explicitly LGBTQ+ founded and led platform matters to you, MISTR is the clearest match. All three are credible, affirming options.